Market Analysis: Global Sepsis Disease Treatment Market

Global sepsis disease treatment market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing demand for antibiotic resistant bacterial strains and growing incidences of hospital acquired infections, development in the healthcare expenditure and rise in investment from government, public & private organizations for the development of novel drugs.

Market Definition: Global Sepsis Disease Treatment Market

Sepsis is a life threatening condition which is caused by the body’s immune response to an infection. Our body releases certain chemicals into the bloodstream to fight infections but when this response is out of balance it triggers inflammation throughout the body that can damage multiple organ systems. A person with sepsis experiences altered mental status, high respiratory rate and low blood pressure.

According to the WHO report, it is estimated that globally every year 3 million newborns and 1.2 million children suffer from sepsis and affect more than 30 million people worldwide and lead to 6 million deaths every year.

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sepsis-disease-treatment-market

Market Restraints

Low healthcare expenditure is restraining the market growth
Lack of awareness in huge number of population in developing regions is hindering the market growth
Introduction of large number of generic medicines is also hampering the market growth

Market Drivers

Increasing demand for antibiotic resistant bacterial strains is driving the market growth
Growing incidences of hospital acquired infections is boosting the market growth
Increasing number of surgical cases leading to post-operative infections is also driving the market growth
High prevalence of numerous chronic diseases such as diabetes is acting as catalyst to market growth
Segmentation: Global Sepsis Disease Treatment Market

By Pathogen Type

Bacteria
Virus
Fungi

By Mechanism of Action

Antibiotics
Corticosteroids
Vasoactive Agents
Analgesics
Others

By Drugs

Vancomycin
Ceftriaxone
Cefuroxime
Tobramycin
Others

By Route of Administration

Oral
Intravenous
Others

By Distribution Channel

Direct
Online Pharmacy
Retailers
Others

By End-Users

Hospitals
Homecare
Specialty Clinics

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia Pacific
South America
Brazil
Rest of South America
Middle East & Africa
South Africa
Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-sepsis-disease-treatment-market

Key Developments in the Market

In April 2019, Beckman Coulter, Inc received the U.S FDA 510(k) clearance for sepsis indicator. Sepsis indicator is first-of-its-kind and based on hematology cellular biomarker, it is designed to help physicians to identify patients with sepsis in an emergency condition or who are at increased risk of developing sepsis
In December 2017, La Jolla Pharmaceutical Company received the U.S FDA approval for Giapreza (angiotensin II) for the treatment of increased blood pressure in patients with septic or other distributive shock. This drug provide potential treatment choices for critically ill hypotensive patients who are not adequately responding to the available treatments

Key Market Players:

The key market players in the global sepsis disease treatment market are Abbott, Pfizer Inc, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Adrenomed AG, AM-Pharma B.V, Amomed Pharma GmbH, Asahi Kasei Corporation, Endacea, Inc, InflaRx N.V,  La Jolla Pharmaceutical Company, Formosa Laboratories, Inc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd, Dascena, Inc, AstraZeneca, Merck & Co., Inc and others.

Competitive Analysis:

Global sepsis disease treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sepsis disease treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.